Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Crit Rev Toxicol ; 45(5): 388-411, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25695728

RESUMO

Tungsten is a relatively rare metal with numerous applications, most notably in machine tools, catalysts, and superalloys. In 2003, tungsten was nominated for study under the National Toxicology Program, and in 2011, it was nominated for human health assessment under the US Environmental Protection Agency's (EPA) Integrated Risk Information System. In 2005, the Agency for Toxic Substances and Disease Registry (ATSDR) issued a toxicological profile for tungsten, identifying several data gaps in the hazard assessment of tungsten. By filling the data gaps identified by the ATSDR, this review serves as an update to the toxicological profile for tungsten and tungsten substances. A PubMed literature search was conducted to identify reports published during the period 2004-2014, in order to gather relevant information related to tungsten toxicity. Additional information was also obtained directly from unpublished studies from within the tungsten industry. A systematic approach to evaluate the quality of data was conducted according to published criteria. This comprehensive review has gathered new toxicokinetic information and summarizes the details of acute and repeated-exposure studies that include reproductive, developmental, neurotoxicological, and immunotoxicological endpoints. Such new evidence involves several relevant studies that must be considered when regulators estimate and propose a tungsten reference or concentration dose.


Assuntos
Compostos de Tungstênio/toxicidade , Poluentes Químicos da Água/toxicidade , Água/química , Animais , Relação Dose-Resposta a Droga , Exposição Ambiental/efeitos adversos , Humanos , Exposição Ocupacional/efeitos adversos , Medição de Risco , Fatores de Risco , Solubilidade , Testes de Toxicidade , Compostos de Tungstênio/química , Compostos de Tungstênio/farmacocinética , Poluentes Químicos da Água/química , Poluentes Químicos da Água/farmacocinética
2.
Artigo em Inglês | MEDLINE | ID: mdl-23682648

RESUMO

Under the European Community (EC) Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), the risk to humans may be considered controlled if the estimated exposure levels to a substance do not exceed the appropriate derived no-effect level (DNEL). In order to address worker exposure, DNELs are derived for the worker population. The most significant route of exposure to workers to both soluble and sparingly soluble tungsten substances is through inhalation. In order to meet the REACH registration requirements, occupational long-term inhalation DNELs were developed according to the European Chemical Agency (ECHA) REACH guidance on characterization of dose-response for human health. The inhalation DNELlong-term for sodium tungstate, from which all other soluble tungsten substance DNELs were derived, is 3 mg sodium tungstate/m(3) (1.7 mg W/m(3)), and the inhalation DNELlong-term for tungsten blue oxide, from which all other sparingly soluble tungsten substance DNELs were derived, is 7.3 mg tungsten blue oxide/m(3) (5.8 mg tungsten/m(3)). Although derived using different methodologies and supported by different studies, the occupational inhalation DNELslong-term for soluble and sparingly soluble tungsten compounds are similar to the current National Institute for Occupational Safety and Health (NIOSH) recommended exposure level (REL) and the American Conference of Industrial Hygienists (ACGIH) threshold limit value (TLV) 8-h time weighted average (TWA) of 1 mg tungsten/m(3) for soluble tungsten compounds and 5 mg tungsten/m(3) as metal and insoluble tungsten compounds.


Assuntos
Exposição por Inalação/normas , Exposição Ocupacional/normas , Compostos de Tungstênio/efeitos adversos , União Europeia , Humanos , Exposição por Inalação/efeitos adversos , Concentração Máxima Permitida , Exposição Ocupacional/efeitos adversos
3.
Inhal Toxicol ; 24(14): 985-94, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23216159

RESUMO

The toxicity and toxicokinetics of tungsten blue oxide (TBO) were examined. TBO is an intermediate in the production of tungsten powder, and has shown the potential to cause cellular damage in in vitro studies. However, in vivo evidence seems to indicate a lack of adverse effects. The present study was undertaken to address the dearth of longer-term inhalation toxicity studies of tungsten oxides by investigating the biological responses induced by TBO when administered via nose-only inhalation to rats at levels of 0.08, 0.325, and 0.65 mg TBO/L of air for 6 h/day for 28 consecutive days, followed by a 14-day recovery period. Inhaled TBO was absorbed systemically and blood levels of tungsten increased as inhaled concentration increased. Among the tissues analyzed for tungsten levels, lung, femur and kidney showed increased levels, with lung at least an order of magnitude greater than kidney or femur. By exposure day 14, tungsten concentration in tissues had reached steady-state. Increased lung weight was noted for both terminal and recovery animals and was attributed to deposition of TBO in the lungs, inducing a macrophage influx. Microscopic evaluation of tissues revealed a dose-related increase in alveolar pigmented macrophages, alveolar foreign material and individual alveolar foamy macrophages in lung. After a recovery period there was a slight reduction in the incidence and severity of histopathological findings. Based on the absence of other adverse effects, the increased lung weights and the microscopic findings were interpreted as nonadverse response to exposure and were not considered a specific reaction to TBO.


Assuntos
Exposição por Inalação , Pulmão/efeitos dos fármacos , Óxidos/toxicidade , Material Particulado/toxicidade , Tungstênio/toxicidade , Aerossóis , Animais , Área Sob a Curva , Biomarcadores/sangue , Biomarcadores/urina , Feminino , Fêmur/metabolismo , Células Espumosas/efeitos dos fármacos , Células Espumosas/imunologia , Células Espumosas/metabolismo , Meia-Vida , Rim/metabolismo , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/patologia , Macrófagos Alveolares/efeitos dos fármacos , Macrófagos Alveolares/imunologia , Macrófagos Alveolares/metabolismo , Masculino , Taxa de Depuração Metabólica , Óxidos/sangue , Óxidos/farmacocinética , Tamanho da Partícula , Material Particulado/sangue , Material Particulado/farmacocinética , Ratos , Ratos Sprague-Dawley , Medição de Risco , Distribuição Tecidual , Tungstênio/sangue , Tungstênio/farmacocinética
4.
Arch Environ Contam Toxicol ; 63(3): 391-9, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22638979

RESUMO

Although aquatic toxicity data exists for tungstate substances, insufficient data of high quality and relevancy are available for conducting an adequate risk assessment. Therefore, a series of acute and chronic toxicity tests with sodium tungstate (Na(2)WO(4)) were conducted on an aquatic invertebrate (Daphnia magna), green alga (Pseudokirchneriella subcapitata), and zebrafish (Danio rerio). Collectively, the data from these studies suggest that sodium tungstate exhibits a relatively low toxicity to these taxa under these test conditions. All studies were conducted in the same laboratory under good laboratory practice standards using Organisation for Economic Co-operation and Development guidelines with the same stock of test material and the same analytical methods. All results are reported as mg W/L. The following toxicity values were based on mean measured concentrations. For D. magna, the 21 day test no-observable effect concentration (NOEC) was 25.9 mg W/L, and the 48-h median effective concentration (EC(50)) from the acute test was >95.5 mg W/L (the highest concentration tested). The P. subcapitata test yielded an ErC(50) of 31 mg W/L. A 38-day test with zebrafish resulted in an NOEC ≥5.74 mg W/L with no effects at any concentration. The 96-h LC(50) from the acute test with zebrafish was >106 mg W/L. The results of the current acute study for daphnids and fish are consistent with published literature, whereas the algae results are different from previously reported values. Transformation/dissolution (T/D) studies, which were conducted according to United Nations Globally Harmonized System of Classification and Labelling of Chemicals protocol, confirmed that the WO (4) (-2) anion accounted for most of the tungsten in solution. For classification purposes, the algae ecotoxity reference value was then compared with T/D data and would not classify Na(2)WO(4) as an aquatic toxicant under the European Union Classification, Labelling and Packaging scheme.


Assuntos
Compostos de Tungstênio/toxicidade , Poluentes Químicos da Água/toxicidade , Animais , Clorófitas , Daphnia , Relação Dose-Resposta a Droga , Medição de Risco , Testes de Toxicidade Aguda , Testes de Toxicidade Crônica , Peixe-Zebra
5.
Environ Toxicol Chem ; 30(10): 2312-8, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21805499

RESUMO

Due to unknown effects of the potential exposure of the terrestrial environment to tungsten substances, a series of toxicity studies of sodium tungstate (Na(2) WO(4) ) was conducted. The effect on earthworm (Eisenia fetida) survival and reproduction was examined using Organisation for Economic Co-operation and Development (OECD) Guideline 222. No effect on either endpoint was seen at the highest concentration tested, resulting in a 56-d no-observed-effect concentration (NOEC) of ≥586 mg tungsten/kg dry soil (nominal concentrations). The effect of sodium tungstate on emergence and growth of plant species was examined according to OECD Guideline 208: oat (Avena sativa), radish (Raphanus sativus), and lettuce (Lactuca sativa). No effects on emergence, shoot height, and dry shoot weight were observed in oats exposed to the highest concentration, resulting in a 21-d NOEC of ≥586 mg tungsten/kg dry soil. The NOECs for radish and lettuce were 65 and 21.7 mg tungsten/kg dry soil (nominal concentrations), respectively. Respective 21-d median effective concentration values (EC50) for radish and lettuce were >586 and 313 mg tungsten/kg dry soil (based on shoot height) (confidence level [CL] -8.5-615); EC25 values were 152 (CL 0-331) and 55 (CL 0-114) mg tungsten/kg dry soil. Results are consistent with the few other tungsten substance terrestrial toxicity studies in the literature.


Assuntos
Avena/efeitos dos fármacos , Lactuca/efeitos dos fármacos , Oligoquetos/efeitos dos fármacos , Raphanus/efeitos dos fármacos , Compostos de Tungstênio/toxicidade , Animais , Avena/crescimento & desenvolvimento , Lactuca/crescimento & desenvolvimento , Nível de Efeito Adverso não Observado , Oligoquetos/crescimento & desenvolvimento , Raphanus/crescimento & desenvolvimento , Reprodutibilidade dos Testes , Reprodução/efeitos dos fármacos , Plântula/efeitos dos fármacos , Plântula/crescimento & desenvolvimento , Poluentes do Solo/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA